Low Dose Ruxolitinib in Indian Haplo-Identical Transplant Patients with Steroid Refractory Acute Graft Versus Host Disease

被引：0
|
作者：
Kumar, Kishore [1 ]
Prabhu, Durai [2 ]
Kandan, Mani [3 ]
Thooran, Sen [3 ]
Subash, Chezhian [1 ]
机构：
[1] MIOT Inst Haematol, Chennai, Tamil Nadu, India
[2] MIOT Int Hosp, Chennai, Tamil Nadu, India
[3] MIOT, Chennai, Tamil Nadu, India
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-157269
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：12893 / 12894
页数：2
相关论文
共 50 条
  • [1] Efficiency and Toxicity of Ruxolitinib as the Salvage Treatment in Steroid-Refractory Acute Graft-Versus-Host Disease after Haplo-Identical Stem Cell Transplantation
    Liu, Yin
    Fan, Yi
    Zhang, Wenli
    Chen, Jia
    Cheng, Qiao
    Ma, Xiao
    Lin, Zhihong
    Wu, Depei
    Xu, Yang
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (04): : 332.e1 - 332.e8
  • [2] Ruxolitinib for steroid-refractory acute graft-versus-host disease
    Toama, Wael
    Fiala, Mark
    Pusic, Iskra
    Westervelt, Peter
    Dipersio, John F.
    Schroeder, Mark
    TRANSPLANT INTERNATIONAL, 2020, 33 (02) : 244 - 246
  • [3] Beyond ruxolitinib in steroid-refractory acute graft-versus-host disease
    Lee, Catherine J.
    Pusic, Iskra
    Savani, Bipin N.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (03) : 306 - 307
  • [4] Plasmatic Extracellular Vesicles in Acute Graft-Versus-Host Disease after Haplo-Identical Allografting with Post-Transplant Cyclophosphamide
    Lia, Giuseppe
    Di Vito, Clara
    Tapparo, Marta
    Bruno, Stefania
    Zaghi, Elisa
    Calvi, Michela
    Brunello, Lucia
    Mariotti, Jacopo
    Comba, Lorenzo
    Giaccone, Luisa
    Fasci, Martina
    Boccadoro, Mario
    Evangelista, Andrea
    Castagna, Luca
    Camussi, Giovanni
    Mavilio, Domenico
    Bruno, Benedetto
    BLOOD, 2019, 134
  • [5] Infliximab and Low Dose Alemtuzumab in Patients with Steroid-Refractory Acute Graft-Versus-Host Disease
    Kobrinski, Daniel
    Rodriguez, Tulio E.
    Smith, Scott E.
    Tsai, Stephanie B.
    Al-Mansour, Zeina
    Parthasarathy, Mala
    Stiff, Patrick J.
    BLOOD, 2016, 128 (22)
  • [6] Role of Ruxolitinib in Steroid-Refractory Graft versus Host Disease in Patients Undergoing Allogeneic Stem Cell Transplant
    Javed, Hammad
    Chaudhry, Qamarunnisa
    Shahbaz, Nighat
    Khan, Mehreen Ali
    Iftikhar, Raheel
    Yousaf, Muhammad
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (09): : 1225 - 1227
  • [7] Ruxolitinib for Steroid-Refractory Acute Graft-Versus-Host Diseas
    Toama, Wael
    Fiala, Mark A.
    Pusic, Iskra
    Westervelt, Peter
    DiPersio, John F.
    Schroeder, Mark A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [8] Ruxolitinib as Salvage Therapy in Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Hematopoietic Stem Cell Transplant Patients
    Khandelwal, Pooja
    Teusink-Cross, Ashley
    Davies, Stella M.
    Nelson, Adam S.
    Dandoy, Christopher E.
    El-Bietar, Javier
    Marsh, Rebecca A.
    Kumar, Ashish R.
    Grimley, Michael S.
    Jodele, Sonata
    Myers, Kasiani C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (07) : 1122 - 1127
  • [9] Ruxolitinib versus basiliximab for steroid-refractory acute graft-versus-host disease: a retrospective study
    Liu, Jiapei
    Fan, Zhiping
    Xu, Na
    Ye, Jieyu
    Chen, Yanqiu
    Shao, Ruoyang
    Sun, Yiming
    Wu, Qiaoyuan
    Liu, Qifa
    Jin, Hua
    ANNALS OF HEMATOLOGY, 2023, 102 (10) : 2865 - 2877
  • [10] Ruxolitinib versus basiliximab for steroid-refractory acute graft-versus-host disease: a retrospective study
    Jiapei Liu
    Zhiping Fan
    Na Xu
    Jieyu Ye
    Yanqiu Chen
    Ruoyang Shao
    Yiming Sun
    Qiaoyuan Wu
    Qifa Liu
    Hua Jin
    Annals of Hematology, 2023, 102 : 2865 - 2877
12345